Tetsuhiro Yoshinami

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

June, 2025

Tetsuhiro Yoshinami

Jun 6, 2025, 07:19 | Opinion

Loay Kassem: 11 Pivotal Trials From ASCO 2025 Published in The NEJM

Loay Kassem, Assistant Professor of Clinical Oncology at Kasr AlAiny School of Medicine, shared a post…

Jun 1, 2025, 16:11 | Insight

Erika Hamilton Presented VERITAC-2 Results on Vepdegestrant at ASCO 2025

Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at the Sarah Cannon…

Jan 29, 2025, 08:05 | Blog

Pertuzumab Retreatment for Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced/Metastatic Breast Cancer

Paolo Tarantino, Advanced research fellow at Dana-Farber Cancer Institute, shared a post on X: "Final…

Jan 28, 2025, 15:01 | Insight

Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared a post on X: "Check out the Breast Cancer Research Digest…

All: 4 Posts: 1 - 100

'

Douglas Flora: Fighting Cancer with Heart

'

Eric Small: Deeply Honored to Step Into the Role of 2025-26 ASCO President

'

Cyril Konto: I Trademarked The Word ‘Multispecific’ The Day I Arrived

'

Levi Garraway: Transforming Oncology Through Precision, Resilience And Heart

'

20 Posts Not to Miss from ASCO 2025

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023